B1S logo

YSB Inc.DB:B1S Stock Report

Market Cap €263.1m
Share Price
n/a
1Y-66.5%
7D2.9%
1D-4.3%
Portfolio Value
View

YSB Inc.

DB:B1S Stock Report

Market Cap: €263.1m

YSB (B1S) Stock Overview

Operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. More details

B1S fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

B1S Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
479,582 investors already sharing narratives

YSB Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for YSB
Historical stock prices
Current Share PriceHK$0.35
52 Week HighHK$1.29
52 Week LowHK$0.30
Beta0.47
1 Month Change4.76%
3 Month Change-37.70%
1 Year Change-66.48%
3 Year Changen/a
5 Year Changen/a
Change since IPO-64.08%

Recent News & Updates

Recent updates

Shareholder Returns

B1SDE HealthcareDE Market
7D2.9%3.1%0.1%
1Y-66.5%1.0%-0.5%

Return vs Industry: B1S underperformed the German Healthcare industry which returned 2.6% over the past year.

Return vs Market: B1S underperformed the German Market which returned 0.3% over the past year.

Price Volatility

Is B1S's price volatile compared to industry and market?
B1S volatility
B1S Average Weekly Movement13.0%
Healthcare Industry Average Movement5.1%
Market Average Movement5.3%
10% most volatile stocks in DE Market12.7%
10% least volatile stocks in DE Market2.7%

Stable Share Price: B1S's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: B1S's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20156,950Buzhen Zhangwww.ysbang.cn

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations.

YSB Inc. Fundamentals Summary

How do YSB's earnings and revenue compare to its market cap?
B1S fundamental statistics
Market cap€263.07m
Earnings (TTM)€19.79m
Revenue (TTM)€2.71b
13.3x
P/E Ratio
0.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B1S income statement (TTM)
RevenueCN¥20.97b
Cost of RevenueCN¥18.66b
Gross ProfitCN¥2.31b
Other ExpensesCN¥2.15b
EarningsCN¥152.97m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.22
Gross Margin11.00%
Net Profit Margin0.73%
Debt/Equity Ratio6.4%

How did B1S perform over the long term?

See historical performance and comparison

Dividends

3.7%
Current Dividend Yield
49%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/22 18:26
End of Day Share Price 2026/07/22 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

YSB Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCMB International Securities Limited
Zhen LiTianfeng Securities Brokerage Co., Ltd